J8510 HCPCS Level II code: Busulfan; oral, 2 mg
J8510 is the HCPCS code for “Busulfan; oral, 2 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8510Busulfan; oral, 2 mg
Short description: Oral busulfan
HCPCS · United States
Medicare details
The indicators CMS publishes with J8510 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2000
Where J8510 sits
- 1J codesDrugs administered other than orally
- 2Active code J8510Busulfan; oral, 2 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8510 mean?
J8510 is the HCPCS code for “Busulfan; oral, 2 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8510?
CMS lists J8510’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8510
All J codesJ7799Noc drugs, other than inhalation drugs, administered through dmeJ7999Compounded drug, not otherwise classifiedJ8498Antiemetic drug, rectal/suppository, not otherwise specifiedJ8499Prescription drug, oral, non chemotherapeutic, nosJ8501Aprepitant, oral, 5 mgJ8502Injection, aprepitant (aponvie), 1 mgJ8515Cabergoline, oral, 0.25 mgJ8520Capecitabine, oral, 150 mgJ8521Capecitabine, oral, 500 mgJ8522Capecitabine, oral, 50 mgJ8530Cyclophosphamide; oral, 25 mgJ8540Dexamethasone, oral, 0.25 mg